Epsilon Pharma signs manufacturing agreement with Puro NZ
Filed with ASX · · 5 pages · English
• Epsilon Pharma Pty Ltd (a wholly owned subsidiary of Epsilon Healthcare Limited) has entered into a manufacturing agreement with Puro New Zealand Limited ("Puro") • Forecast manufacturing revenue for Epsilon Pharma over the 3-year initial term is AU $6M • Epsilon Pharma will manufacture and prepare GMP certified finished formulation products • An initial term of three years with a full market la
Epsilon Healthcare Limited on 6ix
Earlier from Epsilon Healthcare
- Quarterly Activities/Appendix 4C Cash Flow Report
- Reinstatement to Quotation
- Pre-reinstatement Disclosure
- Strengthening working capital position
- Half Yearly Report and Accounts
Later from Epsilon Healthcare
- Preliminary Final Report
- Change of Director's Interest Notice - Alan Beasley
- Epsilon Progresses Global Manufacturing Opportunity
- Change of Director's Interest Notice - Zoe Hutchings
- Update to Appendix 4C Managing Director Loan
Follow Epsilon Healthcare into a list and get an email when it puts out news.
Follow Epsilon Healthcare